drugset / Trial / NCT00636103

Efficacy Study of Herbal Formula CUF2 to Treat Childhood Asthma

NCT00636103 ↗

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Asthma is a long-term disease process with genetic, allergic, environmental, infectious, emotional and dietary influences. The symptoms control are mainly using an inhaled drug, avoiding triggers or taking preventive medicine. Although side effects are unlikely at low dose of the asthma treatment, they have become apparent at the higher dose. Due to safety concern, parents often turn to complementary and alternative medicine which they believe is natural and safe and may help to reduce the conventional medication dosage. There are number of reports that treatment with traditional Chinese herbs or formulas resulted in significant improvement in lung function and reduction in the airway hyper-reactivity reaction. Our study drug CUF2, was based on a classical formulae and had been proven to have anti-inflammatory and immunomodulatory activities in laboratory and animal studies. With the pre-clinical evidence, this study aims to determine the effect of CUF2 on improving the clinical symptoms, biochemical markers, and requirement of steroid dosage among children with asthma.

Timeline

Start
2002-07
Primary completion
2003-08
Completion
2003-08

Outcome

Missed primary endpoint

paper The comparison between the CUF2 group and the placebo group showed no significant difference on the dosage of steroids (-2.3 versus -3.1 mg, p = 0.915). PMID 19821718 ↗

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject CUF2 Unknown 0.619 g Oral

Indications